Correction: Novel anilino quinazoline-based EGFR tyrosine kinase inhibitors for treatment of non-small cell lung cancer

Correction: Novel anilino quinazoline-based EGFR tyrosine kinase inhibitors for treatment of non-small cell lung cancer

Correction for 'Novel anilino quinazoline-based EGFR tyrosine kinase inhibitors for treatment of non-small cell lung cancer' by Lili Yang et al. , Biomater. Sci. , 2021, 9 , 443-455. DOI: 10.1039/D0BM00293C .

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biomaterials science 2022-05, Vol.1 (1), p.272-2722
Hauptverfasser: Yang, Lili, Liu, Shanshan, Chu, Jingjing, Miao, Shuang, Wang, Kai, Zhang, Qingwei, Wang, Yingyi, Xiao, Yadi, Wu, Lina, Liu, Yang, Yu, Longjian, Yu, Caihong, Liu, Xiang, Ke, Mingxing, Cheng, Zhen, Sun, Xilin
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Correction for 'Novel anilino quinazoline-based EGFR tyrosine kinase inhibitors for treatment of non-small cell lung cancer' by Lili Yang et al. , Biomater. Sci. , 2021, 9 , 443-455. DOI: 10.1039/D0BM00293C .
ISSN:2047-4830
2047-4849
DOI:10.1039/d2bm90028a